Navigation Links
PharmAthene Reports First Quarter 2012 Financial Results
Date:5/8/2012

s payable$

1,410,516$

1,445,700Accrued expenses and other liabilities2,850,0723,169,642Current portion of long term debt195,412-Short term debt857,808-Total current liabilities5,313,8084,615,342Other long term liabilities555,983449,709Long term debt, less current portion2,234,712-Derivative instruments2,878,3141,886,652Total liabilities10,982,8176,951,703Stockholders' equity:Common stock, $0.0001 par value; 100,000,000 shares authorized;
48,314,510 and 48,236,172 shares issued and outstanding at March 31, 2012
and December 31, 2011, respectively4,8324,824Additional paid-in-capital209,111,489208,525,917Accumulated other comprehensive income1,023,8911,010,522Accumulated deficit(196,369,345)(193,689,457)Total stockholders'
equity13,770,86715,851,806Total liabilities and stockholders' equity$

24,753,684$

22,803,509 PHARMATHENE, INC. 

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONSThree months ended March 31,20122011Revenue

$

6,149,052$

6,337,722Operating expenses:Research and development4,705,3575,820,374General and administrative2,948,4814,939,654Depreciation and amortization85,910117,629Total operating expenses7,739,74810,877,657Loss from operations(1,590,696)(4,539,935)Other income (expense):Interest income2,9883,154Interest expense(3,028)(15,435)Other income (expense)52,915(11,906)Change in fair value of derivative instruments(991,662)2,488,465Total other income (expense)(938,787)2,464,278Net loss before income taxes(2,529,483)(2,075,657) Income tax expense(150,405)- Net loss

$

(2,679,888)$

(2,075,657)Basic and diluted net loss per share

$

(0.06)$

(0.04)Weighted average shares used in calculation of
basic and diluted net loss per share48,269,89446,276,874 


'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. PharmAthene Presents Update on SparVax™ rPA Anthrax Vaccine Program at the 2012 World Vaccine Congress
2. PharmAthene Secures $7.5 Million Credit Facility From GE Capital, Healthcare Financial Services
3. PharmAthene to Present at the 24th Annual ROTH Conference on Monday, March 12, 2012
4. PharmAthene to Present at the Noble Financial Eighth Annual Equity Conference on Tuesday, January 17, 2012
5. PharmAthene Reports Third Quarter 2011 Financial and Operating Results
6. PharmAthene Progresses Second Generation rPA Anthrax Vaccine
7. PharmAthene Appoints Brian A. Markison to the Companys Board of Directors
8. PharmAthene Achieves Significant Progress in SparVax™ Anthrax Vaccine Program
9. Department of Defense Awards $5.7 Million Contract to PharmAthene for Nerve Agent Medical Countermeasure Program
10. PharmAthene Selected for Inclusion in the Russell Global Index and Russell 3000 Index
11. PharmAthene Achieves Anthrax Vaccine Program Milestone and Successfully Completes Technology Transfer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 19, 2014 Decision Resources Group finds that ... a 12 percent compound annual growth rate through 2023. ... population and the increasing adoption of dental implants. Growing ... will also spur demand for dental biomaterials because they ... periodontal treatments. Other key findings from Decision ...
(Date:12/19/2014)... ME (PRWEB) December 18, 2014 Ed ... director of the Center for Excellence in the Neurosciences ... New England, has been selected as a member of ... is the first neuroscientist from Maine to receive this ... nonprofit organization supported entirely by the Dana Foundation. ...
(Date:12/19/2014)... December 18, 2014 With only 2 ... special on Sartorius Biohit products . The product ... pipettes, Picus Electronic Pipette Trade-in Program, and free pipette ... Safety officers around the world. They are ideal for ... features include:, ,     Full volume range of ...
(Date:12/17/2014)... NY (PRWEB) December 16, 2014 The ... changes since 2013, which is why IBISWorld updated its ... industry continues to benefit from an intensified focus on ... proposal for new emission standards for power plants and ... operators. According to IBISWorld Industry Analyst Sarah Kahn, “a ...
Breaking Biology Technology:Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 2UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 3Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3
... Inc. announced Tuesday that its genetic analysis ... chromosomal analysis, opening a new market to the ... extension of the Invader technology, Madison-based Third Wave ... (ASRs) for prenatal chromosomal analysis to the University ...
... Wisconsin forum in Eau Claire Thursday, Gov. Doyle announced ... $250,000 in Technology Zone tax credits. The award will ... at its Chippewa Falls facility and invest $8.2 million ... computer circuit boards. The company has three facilities, with ...
... Voss looks at the future in terms of social, ... upcoming trends in the technology needed by certain segments ... from the University of Wisconsin-Madison addressed the Madison chapter ... titled Americas Changing Demographic Portrait. He said the United ...
Cached Biology Technology:Using Demographic Predictions, UW Prof Expounds Upon Trends in Tech 2
(Date:12/19/2014)... Calif. , Dec. 18, 2014  23andMe, Inc., ... of a study that pinpoints fine-scale differences in genetic ... States . Since immigrants first arrived ... United States has served as a meeting ... how American history and the ongoing mixing of peoples ...
(Date:12/17/2014)... , Dec. 15, 2014 Research and Markets ... addition of the "Samsung Galaxy S5 - ... report to their offering. ... totally different sensing technology than the iPhone 5S, ... sensor in its product. The Galaxy ...
(Date:12/17/2014)... YORK , Dec. 15, 2014  HITLAB ... Good Clinical Practices (GCP) audit to confirm its ... (FDA) regulations. This accomplishment enables HITLAB to conduct ... utilizing the highest principles for patient safety and ... improve global healthcare access, quality, and delivery with ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2
... shows that honey bees "self-medicate" when their colony is ... of antifungal plant resins to ward off the pathogen. ... and effort of its worker bees to collect these ... in NC State,s Department of Entomology and lead author ...
... a cantaloupe from the grocery store? Too ripe? Not ripe ... Davis might have found a way to make imperfectly ripe ... published on March 30 in the Journal of Visualized ... a project geared towards developing rapid methods to evaluate ripeness ...
... Network ( http://www.plantcyc.org/ ), which is based at Carnegie,s ... databases that offer an unprecedented view of the biochemical ... and cassavafour important species of crop plant. The new ... working with these species to increase crop production, enhance ...
Cached Biology News:Bees 'self-medicate' when infected with some pathogens 2The electronic nose knows when your cantaloupe is ripe 2New databases harvest a rich bounty of information on crop plant metabolism 2
Request Info...
RABBIT ANTI PORCINE CARBOXYPEPTIDASE B...
albumin from bovine serum (BSA), Texas Red® conjugate...
Mycoplasma Removal Agent (MRA) has been developed for cell culture, to combat the widespread problems caused by contamination of cell cultures with mycoplasma....
Biology Products: